Back
ESC2025 Premium Access

BW-00112 targeting ANGPTL3 results in prolonged reductions in plasma triglycerides, LDL-C, and remnant-C in Chinese healthy subjects

Session: Drug therapy (1)
Topic: Drug therapy
Speaker: Ms Y. Li (Shanghai, CN)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Ms Yuqiong Li

Shanghai (China)
0 follower

7 more presentations in this session

The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan

Speaker: Professor P. Liu (Tainan, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Prospective validation of a self-report-based model for coronary artery calcium screening and assessment of treatment gaps in lipid-lowering therapy.

Speaker: Doctor E. Hagberg (Gothenburg, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM

Speaker: Professor M. Miller (Philadelphia, US)

Access
Abstract
Slides
Video
Like
Thumbnail

PCSK-9-inhibitor therapy improves endothelial function in patients with coronary artery disease

Speaker: Doctor A. Bosch (Erlangen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Effectiveness of statins for primary prevention in the elderly - a propensity score matched cohort study

Speaker: Doctor D. Leibowitz (Jerusalem, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Drug therapy (1)

Speakers: Ms Y. Li, Professor P. Liu, Doctor E. Hagberg, Professor M. Miller, Doctor A. Bosch...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources